Michele Connell

Michele Connell currently serves as Senior Director of Drug Safety & Pharmacovigilance at BridgeBio since March 2025. Previously, Michele held roles at Lykos Therapeutics, including Senior Quality Associate and Senior Quality Assurance Pharmacovigilance Consultant, focusing on pharmacovigilance audits and regulatory inspections. At Spectrum Pharmaceuticals, Michele progressed from Associate Director to Senior Director of Pharmacovigilance Operations, overseeing safety operations and end-to-end case processing. Additionally, roles included Assistant Director at the University of California, Irvine Extension, where Michele developed a Regulatory Affairs and Compliance Certificate Program, and independent consulting in pharmacovigilance from 2011 to 2016. Michele earned a Doctor of Pharmacy from the University of California, San Francisco, and a Bachelor of Science in Psychobiology from UCLA.